GD
Grandfield & Dodd Portfolio holdings
AUM
$1.77B
1-Year Est. Return
21.17%
This Fund
S&P 500
1 Year Est. Return
+21.17%
AUM
$1.77B
AUM Growth
+$2.82M
(+0.16%)
Holding
216
Top Buys
| 1 | +$2.62M | |
| 2 | +$1.8M | |
| 3 | +$851K | |
| 4 |
PPG Industries
PPG
|
+$831K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$608K |
Top Sells
| 1 | +$5.02M | |
| 2 | +$4.81M | |
| 3 | +$4.74M | |
| 4 |
Gilead Sciences
GILD
|
+$3.44M |
| 5 |
RTX Corp
RTX
|
+$2.53M |
Sector Composition
| 1 | Technology | 29.1% |
| 2 | Industrials | 19.03% |
| 3 | Healthcare | 15.88% |
| 4 | Financials | 9.21% |
| 5 | Materials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bank of New York Mellon
BK
$80B
| $208K | 0.01% |
+1,788
|
|
||
202
iShares Core MSCI Emerging Markets ETF
IEMG
$135B
| $204K | 0.01% |
+3,032
|
|
||
203
Texas Instruments
TXN
$174B
| $203K | 0.01% |
+1,172
|
|
||
204
iShares Russell 1000 Value ETF
IWD
$67.8B
| $201K | 0.01% |
955
-300
|
|
||
205
Equinix
EQIX
$95.3B
| $201K | 0.01% |
262
|
|
||
206
Iovance Biotherapeutics
IOVA
$1.63B
| $180K | 0.01% |
65,930
-11,895
|
|
||
207
PDS Biotechnology
PDSB
$34.5M
| $7.7K | ﹤0.01% |
10,000
|
|
||
208
DuPont de Nemours
DD
$18.4B
| – | – |
-10,456
|
|
||
209
Deere & Co
DE
$156B
| – | – |
-1,339
|
|
||
210
EOG Resources
EOG
$71.7B
| – | – |
-3,084
|
|
||
|
FISV
211
Fiserv Inc
FISV
$30.3B
| – | – |
-3,190
|
|
||
212
Genuine Parts
GPC
$14.7B
| – | – |
-1,698
|
|
||
|
K
213
DELISTED
Kellanova
K
| – | – |
-3,194
|
|
||
214
Marathon Petroleum
MPC
$66.7B
| – | – |
-1,188
|
|
||
215
Nucor
NUE
$37.2B
| – | – |
-1,985
|
|
||
216
John Wiley & Sons Class A
WLY
$1.93B
| – | – |
-5,555
|
|